Cargando…
Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells
Huntington disease (HD) is a devastating and presently untreatable neurodegenerative disease characterized by progressively disabling motor and mental manifestations. The sigma-1 receptor (σ1R) is a protein expressed in the central nervous system, whose 3D structure has been recently determined by X...
Autores principales: | Battista, Theo, Pascarella, Gianmarco, Staid, David Sasah, Colotti, Gianni, Rosati, Jessica, Fiorillo, Annarita, Casamassa, Alessia, Vescovi, Angelo Luigi, Giabbai, Barbara, Semrau, Marta Stefania, Fanelli, Sergio, Storici, Paola, Squitieri, Ferdinando, Morea, Veronica, Ilari, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865886/ https://www.ncbi.nlm.nih.gov/pubmed/33525510 http://dx.doi.org/10.3390/ijms22031293 |
Ejemplares similares
-
Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington's disease therapy
por: Carbo, Miriam, et al.
Publicado: (2019) -
Investigation of the Entry Pathway and Molecular Nature of σ1 Receptor Ligands
por: Pascarella, Gianmarco, et al.
Publicado: (2023) -
Huntingtin Ubiquitination Mechanisms and Novel Possible Therapies to Decrease the Toxic Effects of Mutated Huntingtin
por: Fiorillo, Annarita, et al.
Publicado: (2021) -
Targeting Trypanothione Reductase, a Key Enzyme in the Redox Trypanosomatid Metabolism, to Develop New Drugs against Leishmaniasis and Trypanosomiases
por: Battista, Theo, et al.
Publicado: (2020) -
Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target
por: Battista, Theo, et al.
Publicado: (2020)